Gene fusions, arising from chromosomal rearrangements or aberrant splicing events, generate chimeric transcripts that can drive oncogenesis through novel protein products or altered gene regulation.
IRVINE, Calif., Jan. 21, 2026 /PRNewswire/ -- Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation Sequencing (NGS) leader in ...
Cancer can begin changing at the molecular level long before its presence becomes obvious through conventional clinical signs ...
Found in 70 percent of cancers, the gene is seen as a grand orchestrator but has been surprisingly difficult to stop.
Professor, Department of Genetics and Genome Sciences, School of Medicine Professor, Department of Molecular Biology and Microbiology, School of Medicine Sanford (Sandy) Markowitz is the ...
Enhancers are pieces of DNA that act like switches, regulating when genes are turned on and off and how strongly they are activated. Scientists know these switches play a critical role in cancer and ...
A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...
Artificial intelligence is helping scientists read gene behavior more like language, revealing how genes cluster, shift roles, and shape disease. A new model from Mount Sinai learns from vast datasets ...